Atlas Trials

Malignant Melanoma Stage IV

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Malignant Melanoma Stage IV

RecordFirmDate
Vemurafenib Plus Cobimetinib After Radiosurgery in Patients With BRAF-mutant Melanoma Brain Metastases (NCT03430947)Technische Universität Dresden2018-07-01
Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT ) (NCT03493230)Centre Hospitalier Universitaire de Nice2018-04-24
Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients (NCT03166397)Sheba Medical Center2017-06-05
Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain (NCT02439411)Grupo Español Multidisciplinar de Melanoma2015-03-03
Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI (NCT03132090)University Hospital Tuebingen2014-09-29
Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib (NCT01983124)Paola Queirolo2013-02-01
mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma (NCT01676779)Universitair Ziekenhuis Brussel2012-10-01
Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma (NCT01302496)Bart Neyns2011-02-01
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma (NCT01189383)Baylor Research Institute2011-01-01
Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients (NCT00722098)Baylor Research Institute2008-06-01
Combined Modality Treatment for Patients With Stage IV Melanoma (NCT00313235)Baylor Research Institute2006-03-01

Track Malignant Melanoma Stage IV automatically

Every clearance here is in the API, with alerts when new ones post.